Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.01 USD | +0.25% | -0.50% | -41.67% |
May. 06 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
Apr. 16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.67% | 36.99M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- HC Wainwright Adjusts Price Target on SAB Biotherapeutics to $6 From $10, Maintains Buy Rating